The data reveals Malta leading with a significant share of 29.2% in top-cited biotech publications, followed by Singapore at 24.59%. Notably, traditionally dominant biotech entities like the United States (12.19%) and China (14.54%) are ranked lower, indicating shifts towards smaller nations gaining prominence. Emerging countries like Malaysia and Saudi Arabia showcase promising shares, indicating a diversification in top-tier research locations. Established European research hubs like the Netherlands, Sweden, and the UK display competitive shares, but aren't leading the ranks.
Future trends to observe include:
- The rise of smaller and emerging nations in high-impact biotechnology research.
- The potential decline or stabilization in top-cited publications for traditionally dominant countries such as the US and China.
- Increased collaborations between leading biotech nations and innovative smaller nations.
- Continued geographical diversification of top-tier biotech research outputs globally.
Top countries in Share of Scientific Publications Among the World's 10% Top-Cited Publications in Biotechnology by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Malta | 29.2 | 2023 | View data |
| 2 | 2 Singapore | 24.59 | 2023 | View data |
| 3 | 3 Romania | 21.08 | 2023 | View data |
| 4 | 4 Luxembourg | 17.22 | 2023 | View data |
| 5 | 5 Australia | 16.18 | 2023 | View data |
| 6 | 6 China | 14.54 | 2023 | View data |
| 7 | 7 Sweden | 13.9 | 2023 | View data |
| 8 | 8 United Kingdom | 13.11 | 2023 | View data |
| 9 | 9 Switzerland | 13.03 | 2023 | View data |
| 10 | 10 Costa Rica | 12.76 | 2023 | View data |
